Articles

Independent signal analyses using the project's standard disproportionality methodology.

Inside the AEMS Data: What 4.8 Million Reports Do and Don't Tell You

2026-07-14

The FDA's Adverse Event Monitoring System, the quarterly public data behind our analyses, and why the strongest raw 'signal' is usually an artifact — not a discovery.
Tested Against VAERS: Christine Cotton's Safety Claims and the Post-Market Record

2026-06-13

The categories of adverse event the French biostatistician flagged in Pfizer's Comirnaty trial — cardiac, reproductive/menstrual, thrombotic, stroke — tested against the VAERS signal database with the project's 4-method consensus filter.
Independent Reanalysis: COVID/Shingles Vaccine Signals Amid FDA Publication Blocks

2026-05-12

Cardiac, neurological, and thrombotic signals in VAERS for nine COVID-19 vaccines and three shingles products — applied with the project's standard 4-method consensus filter.
COVID-19 Vaccine Safety Signals in VAERS

2026-05-04

Bayesian disproportionality analysis across nine vaccine products — TTS, myocarditis, neurological, and allergic signals with first-detection dates.